Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teprenone versus sucralfate for chronic non-atrophic erosive gastritis
ChiCTR-TRC-11001170Phase 4Completed
- Sponsor
- Changhai Hospital
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of teprenone in chronic erosive gastritis (2 arms), sponsored by Changhai Hospital. Primary endpoint: Difference in modified Lanza score after 4 weeks. Started Feb 2011; status: completed.
02
Drugs
teprenone
03
Conditions
chronic erosive gastritis
Beyond the preview
Go deeper on ChiCTR-TRC-11001170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001170.